# metabion completes multi-million euro oligonucleotide capacity expansion in Munich

metabion announced on July 11, 2023 that it has completed a double-digit million euro investment in the first quarter of 2023 to expand its oligonucleotide manufacturing capacity at a new facility in Munich East, Germany. The facility serves diagnostic and therapeutic oligonucleotide production.

- Type: Expansion
- Announced: 2023-07-11
- Where: Munich East, Germany
- Value: $11.0M (10.0M EUR)
- Starts operating: Q1 2023
- Status: completed
- Products: oligonucleotides, diagnostic oligonucleotides, therapeutic oligonucleotides
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [metabion](https://endata.com/companies/71451.md)

## Sources

- [biopharminternational.com](https://www.biopharminternational.com/view/metabion-expands-oligonucleotide-production-capacity-in-germany), 2023-07-14: "With this investment, we are strengthening our CMO segment and are committed to further expanding our growth area of business."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.